Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
McKinsey
Moodys
Boehringer Ingelheim
Harvard Business School

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC (M.D.N.C. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC (M.D.N.C. 2015)

Docket   Start Trial Date Filed 2015-03-27
Court District Court, M.D. North Carolina Date Terminated 2017-11-20
Cause 15:1126 Patent Infringement Assigned To Catherine Caldwell Eagles
Jury Demand Both Referred To Joi Elizabeth Peake
Parties SYNGENTA CROP PROTECTION, LLC; UNITED STATES OF AMERICA; WILLOWOOD AZOXYSTROBIN, LLC; WILLOWOOD LIMITED; WILLOWOOD USA, LLC; WILLOWOOD, LLC
Patents 10,183,020
Attorneys ALAN W. DUNCAN; BARRY S. NEUMAN; HARI SANTHANAM; KOURTNEY BALTZER; LESLIE COOPER HARRELL; MEREDITH ZINANNI; PETER J. DAVIS; RICHARD A. COUGHLIN; RUSSELL E. LEVINE; SCOTT A. SKILES; STEVEN E. TILLER; WALTER W. BROWN
Firms Department of Justice; Fox Rothschild LLP; Kirkland & Ellis LLP; Kirkland & Ellis, LLP; Mullins Duncan Harrell & Russell, Pllc; Whitefield Taylor Preston, LLP, Seven; Whiteford Taylor & Preston, LLP; Whiteford, Taylor & Preston LLP
Link to Docket External link to docket
Small Molecule Drugs cited in SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC (M.D.N.C. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 234 Trial Brief Heinze Tr. at 152:3–153:5, 173:2–175:16, 180:10–183:20.) Less than ten days later, Willowood offered…compound. These patents are U.S. Patent Nos. 5,602,076 (“’076 Patent”), 5,633,256 (“’256 Patent”), 5,847,138…infringement of the Compound Patents was willful. The ’138 Patent (“Process Patent”) is directed to a process…infringement of the Process Patent was willful. The ’761 Patent (“DABCO Patent”) is directed to a process… The ’138 Patent expired eighteen months after the Compound Patents, and the ’761 Patent is in force External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
McKinsey
Johnson and Johnson
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.